NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · IEX Real-Time Price · USD
3.810
+0.130 (3.53%)
At close: May 31, 2024, 4:00 PM
3.760
-0.050 (-1.31%)
After-hours: May 31, 2024, 7:51 PM EDT
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $40.77 million as of May 31, 2024. Its market cap has decreased by -13.44% in one year.
Market Cap
40.77M
Enterprise Value
46.23M
1-Year Change
-13.44%
Ranking
Category
Stock Price
$3.81
Market Cap Chart
Since November 20, 2017, NRx Pharmaceuticals's market cap has decreased from $65.80M to $40.77M, a decrease of -38.04%. That is a compound annual growth rate of -7.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 40.80M | 3.55% |
May 30, 2024 | 39.40M | -3.43% |
May 29, 2024 | 40.80M | -0.49% |
May 28, 2024 | 41.00M | -3.07% |
May 24, 2024 | 42.30M | 9.30% |
May 23, 2024 | 38.70M | -7.19% |
May 22, 2024 | 41.70M | 0.97% |
May 21, 2024 | 41.30M | -4.84% |
May 20, 2024 | 43.40M | 14.51% |
May 17, 2024 | 37.90M | 0.53% |
May 16, 2024 | 37.70M | 8.96% |
May 15, 2024 | 34.60M | 1.76% |
May 14, 2024 | 34.00M | 35.46% |
May 13, 2024 | 25.10M | -1.57% |
May 10, 2024 | 25.50M | 3.66% |
May 9, 2024 | 24.60M | 3.80% |
May 8, 2024 | 23.70M | 0.42% |
May 7, 2024 | 23.60M | -8.17% |
May 6, 2024 | 25.70M | 46.02% |
May 3, 2024 | 17.60M | 1.73% |
May 2, 2024 | 17.30M | -5.46% |
May 1, 2024 | 18.30M | -15.67% |
Apr 30, 2024 | 21.70M | -27.18% |
Apr 29, 2024 | 29.80M | 0.34% |
Apr 26, 2024 | 29.70M | 12.50% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
HCW Biologics | 41.61M |
DURECT | 41.59M |
Matinas BioPharma Holdings | 40.96M |
Bright Green | 40.89M |
NKGen Biotech | 40.82M |
iCAD, Inc. | 40.34M |
Eyenovia | 39.64M |
Acurx Pharmaceuticals | 39.61M |